United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Jun 4, 2026 · Filed Jun 5, 2026

On Jun 4, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$546.28 for US$5.46M under a trading plan, leaving 18,876 shares. Filed Jun 5, 2026 (Form 4).

Sold
10,000 shares
Price
US$546.28 average (US$539.64 to US$550.48)
Value
US$5.46M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 4, 2026Common StockOption exercise10,000US$117.7628,876Direct
Jun 4, 2026Common StockSale120US$539.6428,756Direct
Jun 4, 2026Common StockSale480US$541.1428,276Direct
Jun 4, 2026Common StockSale440US$542.7827,836Direct
Jun 4, 2026Common StockSale1,086US$544.1126,750Direct
Jun 4, 2026Common StockSale1,545US$544.9425,205Direct
Jun 4, 2026Common StockSale1,129US$545.8924,076Direct
Jun 4, 2026Common StockSale1,033US$547.0023,043Direct
Jun 4, 2026Common StockSale2,749US$548.0420,294Direct
Jun 4, 2026Common StockSale1,298US$549.0618,996Direct
Jun 4, 2026Common StockSale120US$550.4818,876Direct

Source

View original at SEC

Related